fda warning letters glp-1 october 2025 news September 15, 2025: Telehealth company must stop implying its compounded GLP -1 is FDA-approved, warns – Partnership for Safe Medicines Compound versions of GLP-1 drugs

Chis BA, Fodor D

In a 2023 animal and laboratory study, researchers suggested that GLP-1 medications could have the following benefits for people with UC: lowering the levels of proinflammatory mediators chemicals that cause inflammation preventing certain important proteins and pathways in the body from becoming overactive, which can contribute to UC repairing damage to the inner lining of the intestines improving the balance of good bacteria in the gut The researchers suggested that GLP-1 medications may be a promising future treatment for UC

(You may still be eligible if you are also enrolled in a standalone Part D plan.) You have a diagnosis of type 2 diabetes or metabolic dysfunction associated steatohepatitis (MASH)

Patients have filed GLP-1 lawsuits (USA Today, Jan 2026) Of federal cases allege gastroparesis MDL case growth since January 2025 The Science Driving the Lawsuits The legal claims rest on mounting scientific evidence

Long-Term Maintenance Strategy When target weight or metabolic markers are achieved, dosing and follow-up frequency are adjusted, ensuring results last

Multi-vial discounts Most research peptide vendors offer tiered pricing for bulk orders